In celebration of his incredible accomplishments as a lymphoma researcher and doctor, his years of contributions to the lymphoma community, and his support of the Lymphoma Research Foundation (LRF), LRF will honor Anas Younes, MD with its Distinguished Leadership Award at its 2019 Annual Gala, to be held on September 26th in New York City.
A world-renowned expert of both Hodgkin and non-Hodgkin lymphoma, Dr. Younes is the Special Advisor to the Chief of Medicine for Research and the Steven Greenberg Chair at Memorial Sloan Kettering Cancer Center (MSK). Prior to this position, Dr. Younes served as the Chief of Memorial Sloan Kettering’s Lymphoma Service for six years. He joined MSK in 2013 with two decades of experience in lymphoma care and research at MD Anderson in Houston.
As a researcher, he has served as the principle investigator of numerous clinical trials and has led the efforts to develop the first FDA-approved targeted drug for the treatment of Hodgkin lymphoma in more than three decades
(brentuximab vedotin) and the first immune checkpoint inhibitor for lymphoma (nivolumab). At both MD Anderson and MSK he has led an NCI-funded Special Program of Research Excellence (SPORE) in lymphoma focused on developing novel treatment strategies for Hodgkin and non-Hodgkin lymphoma. An expert in lymphoma research, Dr. Younes’ findings have been published in numerous medical journals.
As member of LRF’s Scientific Advisory Board since 2009, he has served as a vital mentor to LRF’s grantees and has even sponsored an early career researcher. In 2018, Dr. Younes served as Grand Marshall of the 2018 New York Lymphoma Walk, helping raise awareness and support for lymphoma and LRF programs. Dr. Younes was the first doctor to participate in LRF’s social media chat series and has been vocal and influential in his support for LRF on his own social media channels.
In addition to his advocacy, Dr. Younes continues to lend his expertise to several LRF patient education resources and programs. His peers know him as a mentor and esteemed colleague who is tireless in his search to improve patient outcomes. Dr. Younes’ legacy is one of immense contributions to the lymphoma community through his commitment to a high level of care, his dedication to novel therapies, and his investment in the future of lymphoma research.
To support Dr. Younes’ fundraising efforts for the 2019 Annual Gala visit, support.lymphoma.org/goto/AnasYounes.
2019 Annual Gala
On September 26, 2019, LRF will host its Annual Gala in New York City, bringing together key leaders from the lymphoma community for an evening of celebration and tribute. The Annual Gala will take place at the Plaza Hotel and the evening program features a cocktail hour, followed by a seated dinner and an awards ceremony, an exciting live auction, and an update on LRF-funded research, programming and patient services. Learn More about this year’s Gala >
